Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Home
Zydus Lifesciences Limited
Press Release Dec 04 2020
Published Dec 4 2020
3 min read

Press Release Dec 04 2020

Cadila Healthcare Limited has informed the Exchange regarding a press release dated December 04, 2020, titled "Zydus receives approval from DCGI to commence Phase III clinical trials with Pegylated Interferon alpha-2b in India".

View Attachment